DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo

Myriad Genetics (NASDAQ: MYGN)

34.85 0.88 (2.59%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MYGN $34.85 2.59%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.13
Previous Close $33.97
Daily Range $33.81 - $34.97
52-Week Range $31.34 - $40.50
Market Cap $2.4B
P/E Ratio 27.18
Dividend (Yield) $0.00 (0.0%)
Volume 521,777
Average Daily Volume 880,287
Current FY EPS $1.46




Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website:

News & Commentary

What Is a Short Squeeze, and How Can it Affect Your Investments?

The stock market is a two-way street, and stocks are just as likely to fall as rise. Find out what some investors do to take advantage of this, and what risks might be involved, including the dreaded short squeeze.

MYGN August 14th Options Begin Trading

Myriad Genetics: Portfolio Offers Hope amid Currency Woes - Analyst Blog

10 Movers To Keep An Eye On This Monday

2 Small Cap Pharma Stocks Credit Suisse Loves

3 Ways Personalized Medicine Could Completely Transform Your Life

The one-size-fits-all doctor-patient relationship that's existed for decades is slowly dying. Instead, an array of new personalized interactions, along with diagnostics, devices, and therapies, are taking its place.

Health Care Sector Update for 05/15/2015: ALDR, MYGN, PTX

Myriad Genetics Q3 Test Growth Impresses Yet Revenues Fall - Analyst Blog

Myriad Genetics Posts In-Line Q3 Earnings, Guides Lower - Analyst Blog

Myriad Genetics' (MYGN) CEO Peter Meldrum on Q3 2015 Results - Earnings Call Transcript

See More MYGN News...

MYGN's Top Competitors

MYGN $34.85 (2.59%)
Current stock: MYGN
AMGN $155.39 (0.58%)
Current stock: AMGN
GILD $115.13 (-0.46%)
Current stock: GILD
BIIB $408.06 (0.85%)
Current stock: BIIB